First-line defences short-lived
First-line immune defences against COVID-19 are short-lived and may explain reinfection. A new study finds that antibodies produced in the…
COVID-19
Third of long Covid patients suffer persistent smell loss
Third of long Covid patients suffer persistent smell loss: Smell loss is one of the most prevalent symptoms of long Covid…
Clamp2 provides vaccine hope for future pandemics
Clamp2 provides vaccine hope for future pandemics: The University of Queensland is set to take a second-generation molecular clamp vaccine…
‘A silent killer’ – COVID-19 shown to trigger inflammation in the brain
‘A silent killer’ - COVID-19 shown to trigger inflammation in the brain: The UQ team was led by Professor Trent…
Finger-prick blood test identifies immunity to COVID-19
A finger-prick blood test can identify people most at risk of being reinfected with COVID-19. The simple test, developed by a…
How COVID-19 damages heart DNA
Study reveals how COVID-19 damages heart DNA: University of Queensland researchers have discovered how COVID-19 damages the heart, opening the…
The effects of Covid-19 on the colon
New findings on the effects of Covid-19 on the colon: Although SARS-CoV-2 infections mainly attack the lungs, in many cases…
Test to help patients manage long COVID at home
A test to help patients manage long COVID at home has been developed. The adapted Autonomic Profile (aAP) test can…
New study to find COVID-fighting drugs
New study to find COVID-fighting properties in existing medications: Nearly 50 existing prescription medications already used by Australians will be…
Insights into when COVID-19 patients ARE infectious
First real-world, peer reviewed study gives detailed new insights into when people with COVID-19 are infectious: Average duration of infectiousness…